![]() | Up a level |
Diamond, Eli L., Subbiah, Vivek ORCID: 0000-0002-6064-6837, Lockhart, A. Craig, Blay, Jean-Yves
ORCID: 0000-0001-7190-120X, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena
ORCID: 0000-0002-4653-6324, Martinez-Valle, Ferran, Durham, Benjamin
ORCID: 0000-0001-8090-5448, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, Jose and Hyman, David M.
(2018).
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
JAMA Oncol., 4 (3).
S. 384 - 389.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2374-2445
Doebele, Robert C., Dziadziuszko, Rafal, Drilon, Alexander, Shaw, Alice T., Wolf, Juergen, Farago, Anna F., Dennis, Lucas, Riehl, Todd, Simmons, Brian, Wu, Charlie, Chang, Ching-Wei, Choeurng, Voleak and Wilson, Timothy R. (2020). Genomic Landscape of Entrectinib Resistance from Circulating Tumor DNA (CTDNA) Analysis in STARTRK-2. Oncol. Res. Treat., 43. S. 217 - 218. BASEL: KARGER. ISSN 2296-5262
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Hyman, David Michael, Kaley, Thomas Joseph, Hollebecque, Antoine ORCID: 0000-0003-2869-7551, Subbiah, Vivek
ORCID: 0000-0002-6064-6837, Ahnert, Jordi Rodon, Lockhart, A. Craig, Keedy, Vicki Leigh, Hofheinz, Railf, Lobbedez, Florence Joly, Blay, Jean-Yves
ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur, Wolf, Juergen, Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany and Baselga, Jose
(2017).
Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study.
J. Clin. Oncol., 35.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Hollebecque, Antoine, Rodon, Jordi, Lockhart, A. Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves
ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur S., Wolf, Jurgen, DeAngelis, Lisa M., Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose and Hyman, David M.
(2018).
BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study.
J. Clin. Oncol., 36 (35).
S. 3477 - 3487.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Subbiah, Vivek ORCID: 0000-0002-6064-6837, Puzanov, Igor, Blay, Jean-Yves
ORCID: 0000-0001-7190-120X, Chau, Ian
ORCID: 0000-0003-0286-8703, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason
ORCID: 0000-0002-4561-6170, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany and Hyman, David M.
(2020).
Pan-Cancer Efficacy of Vemurafenib in BRAF(V)(600)-Mutant Non-Melanoma Cancers.
Cancer Discov., 10 (5).
S. 657 - 664.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 2159-8290